IL17A and Miyoshi myopathy: We analyzed the correlations between the levels of IL-17 and clinical indicators from these 38 incipient MM patients, the levels of IL-17 in group A (serum creatinine ≤ 176.8 μmol/L; n = 22) are lower than group B (serum creatinine ≥ 176.8 μmol/L; n = 16) of MM patients according the DS stages (146.21 ± 30.90 pg/ml vs. 173.19 ± 37.19 pg/ml; p < 0.05, Figure 3B).